Interestingly, there was no significant difference in peak tumor uptake of 177Lu- or 225Ac-PSMA-617 at 4 h after injection; however, increased tumor retention was observed at all subsequent time points for mice treated with 225Ac-PSMA-617 compared with 177Lu-PSMA-617. This evidence concerns the gene FOLH1 and neoplasm.